DataMEDS AI, Inc.(MEDS)

Medical - Distribution · Tampa, FL

$3.15-0.20 (-5.97%)

Delayed quote: Oct 6, 2026, 3:15 PM EDT

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T19:17:35.219Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:17:35.219Z.

Quote observation: 2026-10-06T19:15:16.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 8,264,201
Total debt · period ending 2026-06-30: 32,622,247
Cash · period ending 2026-06-30: 2,456,373
TTM free cash flow · period ending 2026-06-30: -14,806,547

FMP input reference: c94dd91991be4d96189a92c60ca8c4546f597a2bd6811cd9696b114923955f60

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

MEDS EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

MEDS Competitors' EV/FCF Ratio

MEDS

DataMEDS AI, Inc.

Current

Market Cap

$8.26M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HSCS

HeartSciences Inc.

vs MEDS

Market Cap

$8.23M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HCTI

Healthcare Triangle, Inc.

vs MEDS

Market Cap

$8.35M

EV/FCF Ratio

N/A

TTM Avg

12.59x

3Y Avg

12.59x

5Y Avg

12.59x

GTBP

GT Biopharma, Inc.

vs MEDS

Market Cap

$8.15M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

APRE

Aprea Therapeutics, Inc.

vs MEDS

Market Cap

$7.91M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TRAW

Traws Pharma, Inc.

vs MEDS

Market Cap

$7.90M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNSP

CNS Pharmaceuticals, Inc.

vs MEDS

Market Cap

$7.89M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

QNCX

Quince Therapeutics, Inc.

vs MEDS

Market Cap

$7.79M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NDRA

ENDRA Life Sciences Inc.

vs MEDS

Market Cap

$7.79M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JSPR

Jasper Therapeutics, Inc.

vs MEDS

Market Cap

$8.95M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
DataMEDS AI, Inc. (MEDS)	$8.26M	N/A	N/A	N/A	N/A
HeartSciences Inc. (HSCS)vs ›	$8.23M	N/A	N/A	N/A	N/A
Healthcare Triangle, Inc. (HCTI)vs ›	$8.35M	N/A	12.59x	12.59x	12.59x
GT Biopharma, Inc. (GTBP)vs ›	$8.15M	N/A	N/A	N/A	N/A
Aprea Therapeutics, Inc. (APRE)vs ›	$7.91M	N/A	N/A	N/A	N/A
Traws Pharma, Inc. (TRAW)vs ›	$7.90M	N/A	N/A	N/A	N/A
CNS Pharmaceuticals, Inc. (CNSP)vs ›	$7.89M	N/A	N/A	N/A	N/A
Quince Therapeutics, Inc. (QNCX)vs ›	$7.79M	N/A	N/A	N/A	N/A
ENDRA Life Sciences Inc. (NDRA)vs ›	$7.79M	N/A	N/A	N/A	N/A
Jasper Therapeutics, Inc. (JSPR)vs ›	$8.95M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

MEDS EV/FCF Ratio Metrics

MEDS Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics